Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
The Woodlands, TX
A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants - Bakersfield
mi
from
Bakersfield, CA
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Bakersfield
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants - Santa Barbara Office
mi
from
Santa Barbara, CA
Variable Interval Versus Set Interval Aflibercept for DME
Treat and Extend Versus Dosing Every Eight Weeks With Intravitreal Aflibercept Injections for the Treatment of Diabetic Macular Edema (EVADE Study)
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Santa Barbara Office
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Char Eye Ear &Throat Assoc
mi
from
Charlotte, NC
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Char Eye Ear &Throat Assoc
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Assoc. of Cleveland
mi
from
Cleveland, OH
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Assoc. of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Res Institute of Texas
mi
from
Abilene, TX
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Res Institute of Texas
mi
from
Abilene, TX
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
mi
from
Dallas, TX
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Strategic Clinical Research Group, LLC
mi
from
Willow Park, TX
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Strategic Clinical Research Group, LLC
mi
from
Willow Park, TX
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
West Virginia University Eye Institute
mi
from
Morgantown, WV
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
West Virginia University Eye Institute
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Organizacion Medica de Investigacion
mi
from
Buenos Aires,
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Organizacion Medica de Investigacion
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Palmetto Retina Center, LLC
mi
from
Florence, SC
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center, LLC
mi
from
Florence, SC
Click here to add this to my saved trials
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Midwest Vision Research Foundation
mi
from
Chesterfield, MO
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Multicenter, Prospective Epidemiologic Study of the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Midwest Vision Research Foundation
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Hull Eye Center
mi
from
Lancaster, CA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Hull Eye Center
mi
from
Lancaster, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Colorado Retina Associates
mi
from
Golden, CO
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Colorado Retina Associates
mi
from
Golden, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Eye Center of Southern Connecticut
mi
from
Hamden, CT
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Eye Center of Southern Connecticut
mi
from
Hamden, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Bascom Palmer Eye Institute
mi
from
Plantation, FL
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Bascom Palmer Eye Institute
mi
from
Plantation, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Valley Eye Physicians & Surgeons
mi
from
Ayer, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Massachusetts Eye Research and Surgery Institution (MERSI)
mi
from
Waltham, MA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye Research and Surgery Institution (MERSI)
mi
from
Waltham, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Oakland Ophthalmic Surgery
mi
from
Birmingham, MI
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Oakland Ophthalmic Surgery
mi
from
Birmingham, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Lifelong Vision Foundation
mi
from
Chesterfield, MO
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Lifelong Vision Foundation
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Tauber Eye Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
UNMC Stanley Truhlsen Eye Institute
mi
from
Omaha, NE
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
UNMC Stanley Truhlsen Eye Institute
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Metropolitan Eye Research and Surgery Institute
mi
from
Palisades Park, NJ
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Metropolitan Eye Research and Surgery Institute
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Mid-Atlantic Retina
mi
from
Philadelphia, PA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Mid-Atlantic Retina
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Houston Eye Associates
mi
from
Houston, TX
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Houston Eye Associates
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated:  12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis
A Phase 2 Randomized, Investigator-Masked, Comparator-controlled Trial to Evaluate the Safety and Efficacy of NS2 Eye Drops in Patients With Anterior Uveitis
Status: Enrolling
Updated: 12/31/1969
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute
mi
from
Baltimore, MD
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Retina Foundation of the Southwest
mi
from
Dallas, TX
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Retina Foundation of the Southwest
mi
from
Dallas, TX
Click here to add this to my saved trials
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Universitäts Augenklinik - Bonn
mi
from
Bonn,
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4 (STGD4): A Prospective Longitudinal Observational Study of Stargardt Disease Type 4, a PROM1- Related Macular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Universitäts Augenklinik - Bonn
mi
from
Bonn,
Click here to add this to my saved trials
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
Additive Effect of Twice Daily Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue
Status: Enrolling
Updated:  12/31/1969
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)
Additive Effect of Twice Daily Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue
Status: Enrolling
Updated: 12/31/1969
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Arizona
mi
from
Phoenix, AZ
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Retina Centers, P.C.
mi
from
Tucson, AZ
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Retina Centers, P.C.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Retina and Macula Institute
mi
from
Glendale, CA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Retina and Macula Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Atlantis Eye Care
mi
from
Huntington Beach, CA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Atlantis Eye Care
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Northern California Retina Vitreous Medical Group, Inc.
mi
from
Mountain View, CA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Medical Group, Inc.
mi
from
Mountain View, CA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Eye Care Center of Northern Colorado
mi
from
Longmont, CO
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Eye Care Center of Northern Colorado
mi
from
Longmont, CO
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Chicagoland Eye and Retina Foundation
mi
from
Chicago, IL
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Chicagoland Eye and Retina Foundation
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
University Retina and Macula Associates, P.C.
mi
from
Oak Forest, IL
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
University Retina and Macula Associates, P.C.
mi
from
Oak Forest, IL
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Sabates Eye Center Research Division
mi
from
Leawood, KA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Sabates Eye Center Research Division
mi
from
Leawood, KA
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Click here to add this to my saved trials
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated:  12/31/1969
Eye Associates of Northeast Louisiana
mi
from
West Monroe, LA
Phase 4 IOP Signals Associated With ILUVIEN®
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN® (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status: Enrolling
Updated: 12/31/1969
Eye Associates of Northeast Louisiana
mi
from
West Monroe, LA
Click here to add this to my saved trials